Valiant Laboratories is set to launch an IPO which will open on September 27, 2023, and close on October 03, 2023. Through this public offer company wants to raise Rs. 152.46 Crore from the primary market, Company fixed the IPO price of Rs. 140 with a minimum lot of 105 shares, and list on October 11, according to the preliminary papers draft red herring prospectus (DRHP) filed to the capital market regulator SEBI.

VALIANT LABORATORIES is a drug manufacturing company having main focus on manufacturing of famous and most commonly taken pill “Paracetamol” and various grades of it as per the requirement of the customers. The manufacturing facility is located in the state of Maharashtra with 9000 MT per annum capacity.                              

In the fiscal year 2023, the company generated Rs. 33.87 crore in revenue from operations, and Rs. 29.34 crore in the year 2022.

Check out the IPO allotment status on IPO Deliver.

#Valiant Laboratories IPO Object

The company proposed to use the IPO Funds for the below-mentioned purposes:

1. INR 26.56 crore of the total net proceeds fund will be used for the capital expenditure requirement of the company
2. INR 4.50 crore of the total net proceeds fund will be used for working Capital requirement of the company.
3. The rest funds will be used for general corporate purposes and offer expenses.

#Valiant Laboratories Strength

1. Strategically located Manufacturing facilities.
2. Experienced promoters and strong management team
3. Good financial performance
4. Reduce dependency on import raw materials

#Valiant Laboratories Forward Statements (Risk)

1. Single product manufacturing company
2. Limited number of supplier for the raw materials.
3. Inability to successfully implement business plan
4. Inability to collects debts and receivables
5. Inability to identify to evolving preferences/trends/expectations of the market.

#Valiant Laboratories IPO Review & Rating

Issue Size	152.46 crore (Book built issue)
Issue Price	Rs. 133-140 per share
Lot size	105 shares
Market Capitalization	608.30 crore
Profit – 2023	29.00 crore
Total Assets – 2023	212.76 crore
Debt/Equity ratio	0.59
NAV Value	Rs. 30.86 per share
Pre-offer Promoter holding	82.52%
Listing on Stock Exchanges	Mainboard (BSE & NSE)
IPO Deliver Rating	Four

 

#Valiant Laboratories IPO Dates, Price Band, Lot Size & Details

Valiant Laboratories IPO is open on September 27, 2023, and closes on October 03, 2023. The IPO list on October 11, 2023.

Type of issue	Fresh issue
Issue Size	Rs. 152.46 Crore
Price band	Rs. 133-140 per share
Lot size	105 equity shares
Face Value	Rs. 10 each equity share
IPO Open	September 27, 2023
IPO Close	October 03, 2023
IPO Allotment Date	October 06, 2023
Refund Date	October 09, 2023
Listing Date	October 11, 2023
Fresh Issue	Rs. 152.46 Crore (10,890,000 equity shares)

 

#Valiant Laboratories Financials Review (million)

The following table sets forth the summary of financial information of the company for the financial year ending March 31, 2023, 2022 & 2021.

Category	March 31, 2023	March 31, 2022	March 31, 2021
Total Revenue	3,387.72	2,934.72	1,837.81
Net worth	1,004.90	714.60	885.82
Profit after Tax (PAT)	289.98	274.96	305.93
Total Borrowings	594	606.81	3.51

 

#Valiant Laboratories IPO Quantitative Factors

The following table sets forth the summary of financial information of the company for the financial year ending March 31, 2023, 2022 & 2021.

Category	March 31, 2023	March 31, 2022	March 31, 2021
Basic EPS	8.91	9.52	10.83
Diluted EPS	8.91	9.52	10.83
RoNW	28.86	38.48	34.54
NAV	30.86	43.89	84.36

 

#Valiant Laboratories IPO Industry peers

Company	EPS	P/E Ratio	RoNW	NAV
Granuales India	21.05	15.06	18.22	115.52
Jagsonpal Pharma	10.2	41.54	16.82	6.06

 

# Valiant Laboratories Company Promoter

The company has three Promoters

• Shantilal Shivji Vohra
• Shantosh Shantilal Vohra
• M/s. Dhanvallabh Ventures LLP

 

• Pre-offer shareholding: 82.52 % (26,868,380 equity shares)
• The average cost of acquisition for promoter: Rs. 12.56, 22.73 and 22.73 per share.

# Valiant Laboratories IPO Pre-offer and Post-Offer Promoters shareholding

Pre-offer promoter & promoter group shareholding 82.52%

Post-offer promoter & promoter group shareholding …….%

# Valiant Laboratories IPO Reservation

Retail investor (QIB): Not more than 50% of the offer size i.e. 5,445,000 equity shares.

NII: Not more than 15% of the offer size i.e. 16,33,500 equity shares

RII: Not less than 35% of the offer size i.e 38,11,500 equity shares

 

# Valiant Laboratories IPO – DRHP & RHP

Draft Red Herring Prospectus (DRHP) – Click to view/download

Red Herring Prospectus (RHP) – Click to view/download

# Valiant Laboratories IPO Registrar

Link Intime India Private Limited

Tel: +91 810 811 4949 and Email: uds.ipo@linkintime.co.in

Website: www.linkintime.co.in

# Valiant Laboratories IPO lead manager

Unistone Capital Private Limited

Tel No.: +91 22 46464728 and Email: mb@unistonecapital.com

Website: www.unistonecapital.com

#Valiant Laboratories IPO Application

Option-1 Apply for IPO through Internet Banking

• Log into your bank account.
• In the invest Tab, you will see ASBA, click on it.
• Choose to apply for IPO and select the ongoing IPO “Valiant Laboratories Limited”
• Enter the basic details like bid quantity, price, PAN, etc. then proceed with payment.
• After the above steps the respective amount will get blocked till the allotment date and after it will get a refund/debited in case of rejection/allotment respectively.

Option-2 Apply for IPO through a Broker

• Log into your broker account (Upstox/Zerodha etc.)
• Click on the IPO tab and select the ongoing IPO “Valiant Laboratories Limited”
• Enter the basic details like bid quantity, price, PAN, etc. then enter UPI ID and proceed with payment.
• Your funds will get blocked, and once shares have been allotted to you, the respective amount will get debited from your account or get refunded in case no allotment is made to you.

Option-3 Apply for IPO Offline Mode Bank mode

• Visit the nearest branch of your bank
• Fill out the ASBA form and submit it with KYC details
• Your funds will get blocked, and once shares have been allotted to you, the respective amount will get debited from your bank account or refunded in case no allotment is made to you.

Option – 4 Apply for IPO through Stock Exchanges

NSE Form – Click to download

BSE Form – Click to download

Submit the form with your bank/broker.

# Valiant Laboratories Company Details

Valiant Laboratories Limited (Established 2021)

Regd. Off: 104, Udyog Kshetra, Mulund Goregaon Link Road, Mulund West, Mumbai-400080

Tel: +91 2249712001 & Email: complianceofficer@valiantlabs.in

Website: www.valiantlabs.in

Investor Grievances/Compliance Officer: Mrs. Saloni Mehta

Subsidiary Company:

• VASPL

# Valiant Laboratories Company Board (Top 2)

Mr. Velji Karamshi Gogri, Chairman and Independent director

Mr. Santosh Shantilal Vohara, Managing Director 

# Valiant Laboratories IPO – Frequently Asked Questions (FAQ’s)

Q-1 what is Valiant Laboratories IPO Open date?

Ans: Valiant Laboratories IPO opening date is September 27 – October 03, 2023.

Q-2 what is Valiant Laboratories IPO Close date?

Ans: Valiant Laboratories IPO closing date is October 03, 2023

Q-3 What is Valiant Laboratories IPO Listing date?

Ans: Valiant Laboratories IPO listing date is October 11, 2023

Q-4 What is Valiant Laboratories IPO Minimum investment amount?

Ans: Valiant Laboratories IPO minimum investment amount is Rs. 14,700.

Q-5 What is Valiant Laboratories IPO offer issue Size?

Ans: Valiant Laboratories offer an issue size of Rs. 152.46 crores, which comprise fresh issues.

Q-6 What is Valiant Laboratories IPO Price Band?

Ans: Valiant Laboratories IPO price band is Rs 133-140 per share.

Q-7 Is any similar segment/sector listed company in India?

Ans: Yes

Q-8 Is Valiant Laboratories IPO mainboard IPO or SME IPO?

Ans: Valiant Laboratories IPO is a mainboard IPO.

Q-9 Valiant Laboratories IPO Rating by IPO Deliver Team?

Ans: Four Rating